Israel Prepares For Clash With U.S., E.U. Over Drug Patent Policy

Law360, New York (September 13, 2004, 12:00 AM EDT) -- The Israeli government is preparing for an outright confrontation with the U.S. government and pharmaceutical industry with its plans to essentially confine patent rights for drugs to marketing exclusivity, according to reports.

The cabinet’s intention to approve a proposed change in protection for intellectual property rights of international pharmaceutical companies threatens “a crisis in U.S.-Israel trade relations,” financial daily Globes reported.

The proposal under consideration does not meet the demands of U.S. Trade Representative Robert Zoellick, who has threatened to put Israel back on the "priority...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.